Palantir Technologies Braces for High-Stakes Earnings as AI Momentum Collides With Valuation Debate
Wall Street expects explosive growth, but scrutiny around pricing and government reliance remains intense Palantir Technologies (PLTR) is set to ...
Tag: Movers
Serina Therapeutics Advances Parkinson’s Program After Key FDA Green Light
IND clearance positions SER-252 for clinical progress in advanced Parkinson’s disease treatment Serina Therapeutics (SER) announced a significant regulatory milestone ...
Earnings Season Hits Full Throttle as Big Tech and AI Set the Pace for 2026
Strong profit growth, rising expectations, and massive AI investment define a pivotal fourth quarter reporting season The fourth quarter earnings ...
Starbucks Posts First U.S. Same-Store Sales Growth in Two Years
Turnaround gains traction under CEO Brian Niccol as traffic rebounds in the U.S. and China Starbucks (SBUX) delivered a key ...
Robotaxi Prices Are Falling—and the Gap With Uber and Lyft Is Closing
New data shows Waymo cutting fares as traditional ride-hailing gets more expensive, while Tesla looms as a disruptive wildcard Rides ...
GITS Secures Global Rights to ATEEZ Theme Song for The Legend of MegaRace
Deal strengthens IP ownership strategy and launches worldwide promotional campaign tied to the animated franchise Global Interactive Technologies (GITS), a ...
GM Beats Estimates, Raises Dividend, and Launches $6B Buyback as Shares Hit Record High
Strong cash flow and shareholder returns offset EV headwinds and rising cost pressures General Motors (GM) extended its streak of ...
Nvidia Invests $2 Billion in CoreWeave to Scale “AI Factories” for the Next Wave of Demand
The deal deepens a strategic partnership as CoreWeave targets 5 gigawatts of AI data center capacity by 2030 Nvidia (NVDA) ...
IonQ to Buy SkyWater in $1.8B Deal, Bringing Quantum Chipmaking In-House
Acquisition strengthens U.S. supply chain control and accelerates plans for next-generation quantum processors Quantum computing company IonQ (IONQ) announced Monday ...
AI Is Already Transforming Drug Development—Just Not Where Investors Expected
While “AI-discovered” breakthrough medicines are still emerging, pharma is using AI today to cut costs, speed trials, and reduce regulatory ...
